Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 6/20 | 0.36 |
| ▸ | GAA | P10253 | 4/20 | 0.36 |
| ▸ | GFER | P55789 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | RAD52 | P43351 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.36 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 5/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | BPTF | Q12830 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL2540462 | 1.00 | SIGMAR1 (0.41) | SIGMAR1GRM2MAPTGAAGFER | |
| Iodide SCHEMBL2542760 | 1.00 | SIGMAR1 (0.41) | SIGMAR1GRM2MAPTGAAGFER | |
| Iodide SCHEMBL2540177 | 1.00 | SIGMAR1 (0.41) | SIGMAR1GRM2MAPTGAAGFER | |
| Iodide SCHEMBL2537387 | 1.00 | SIGMAR1 (0.41) | SIGMAR1GRM2MAPTGAAGFER | |
| Iodide SCHEMBL2542710 | 1.00 | SIGMAR1 (0.41) | SIGMAR1GRM2MAPTGAAGFER | |
| Iodide SCHEMBL2542802 | 0.99 | SIGMAR1 (0.39) | SIGMAR1GRM2MAPTGAAGFER | |
| SCHEMBL2267717 | 0.99 | SIGMAR1 (0.42) | SIGMAR1GRM2MAPTGAAGFER | |
| SCHEMBL2265925 | 0.99 | SIGMAR1 (0.42) | SIGMAR1GRM2MAPTGAAGFER | |
| SCHEMBL2266689 | 0.99 | SIGMAR1 (0.42) | SIGMAR1GRM2MAPTGAAGFER | |
| SCHEMBL2269584 | 0.99 | SIGMAR1 (0.42) | SIGMAR1GRM2MAPTGAAGFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8043385-B2 | Composition oxidation colouring of keratinic fibres, containing a cationic cellulose ether, a metasilicate and oxidation dyes, method for oxidation colouring and uses thereof | L'OREAL S.A. (FR) | 2011-10-25 | — | — | US | claimed |
| US-20100263138-A1 | COMPOSITION OXIDATION COLOURING OF KERATINIC FIBRES, CONTAINING A CATIONIC CELLULOSE ETHER, A METASILICATE AND OXIDATION DYES, METHOD FOR OXIDATION COLOURING AND USES THEREOF | L'OREAL S.A. (FR) | 2010-10-21 | — | — | US | claimed |
| EP-1428515-B1 | Dyeing composition comprising a tertiary paraphenylenediamine containing a pyrrolidine, and a surfactant; methods and uses | OREAL (FR) | 2008-07-02 | — | — | EP | claimed |
| US-20040250356-A1 | Dyeing composition comprising a cationic tertiary para-phenylenediamine and a particular pearlescent or opacifying agent, methods and uses | L'OREAL (FR) | 2004-12-16 | — | — | US | claimed |
| US-20040226109-A1 | Dye composition comprising a cationic tertiary para-phenylenediamine and a polyol, process therefor and use thereof | L'OREAL (FR) | 2004-11-18 | — | — | US | claimed |
| US-20040216243-A1 | Dye composition comprising a cationic tertiary para-phenylenediamine and a surfactant, processes therefor and uses thereof | L'OREAL (FR) | 2004-11-04 | — | — | US | claimed |
| US-20040211010-A1 | Dye composition comprising a cationic tertiary para-phenylenediamine and a polyol ester, processes therefor and uses thereof | L'OREAL (FR) | 2004-10-28 | — | — | US | claimed |
| US-20040205904-A1 | Dye composition comprising a cationic tertiary para-phenylenediamine and a vitamin derivative, processes therefor and uses thereof | L'OREAL (FR) | 2004-10-21 | — | — | US | claimed |
| US-20040205903-A1 | Dyeing composition comprising a cationic pyrrolidine-based para-phenylenefiamine, a tertiary para-phenylenediamine and a benzomorpholine coupler, methods and uses | L'OREAL (FR) | 2004-10-21 | — | — | US | claimed |
| US-8043385-B2 | Composition oxidation colouring of keratinic fibres, containing a cationic cellulose ether, a metasilicate and oxidation dyes, method for oxidation colouring and uses thereof | L'OREAL S.A. (FR) | 2011-10-25 | — | — | US | disclosed |
| US-20040250356-A1 | Dyeing composition comprising a cationic tertiary para-phenylenediamine and a particular pearlescent or opacifying agent, methods and uses | L'OREAL (FR) | 2004-12-16 | — | — | US | disclosed |
| US-20040231067-A1 | Dyeing composition comprising a cationic tertiary para-phenylenediamine and heterocyclic coupler, methods and uses | L'OREAL (FR) | 2004-11-25 | — | — | US | disclosed |
| US-20040231068-A1 | Dyeing composition comprising a cationic tertiary para-phenylenediamine and a cationic polymer, methods and uses | L'OREAL (FR) | 2004-11-25 | — | — | US | disclosed |
| US-20040226109-A1 | Dye composition comprising a cationic tertiary para-phenylenediamine and a polyol, process therefor and use thereof | L'OREAL (FR) | 2004-11-18 | — | — | US | disclosed |
| US-20040216244-A1 | Dyeing composition comprising a cationic tertiary para-phenylenediamine and an organic diacid, methods and uses | L'OREAL (FR) | 2004-11-04 | — | — | US | disclosed |
| US-20040216246-A1 | Dyeing composition comprising a cationic tertiary para-phenylenediamine and a polymer containing a fatty chain, methods and uses | L'OREAL (FR) | 2004-11-04 | — | — | US | disclosed |
| US-20040216245-A1 | Dyeing composition comprising a cationic tertiary para-phenylenediamine and a para-aminophenol, methods and uses | L'OREAL (FR) | 2004-11-04 | — | — | US | disclosed |
| US-20040211010-A1 | Dye composition comprising a cationic tertiary para-phenylenediamine and a polyol ester, processes therefor and uses thereof | L'OREAL (FR) | 2004-10-28 | — | — | US | disclosed |
| US-20040205904-A1 | Dye composition comprising a cationic tertiary para-phenylenediamine and a vitamin derivative, processes therefor and uses thereof | L'OREAL (FR) | 2004-10-21 | — | — | US | disclosed |
| US-20040205903-A1 | Dyeing composition comprising a cationic pyrrolidine-based para-phenylenefiamine, a tertiary para-phenylenediamine and a benzomorpholine coupler, methods and uses | L'OREAL (FR) | 2004-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040231068-A1 | Dyeing composition comprising a cationic tertiary para-phenylenediamine and a cationic polymer, methods and uses | PHOSPHO1, KRT18, NUP205 | SIGMAR1 555/4885GRM2 3403/4885MAPT 1983/4885 |
| US-20040205903-A1 | Dyeing composition comprising a cationic pyrrolidine-based para-phenylenefiamine, a tertiary para-phenylenediamine and a benzomorpholine coupler, methods and uses | CDC73, KRT18, PAH | SIGMAR1 479/4885GRM2 4023/4885MAPT 1091/4885 |
| US-20040216246-A1 | Dyeing composition comprising a cationic tertiary para-phenylenediamine and a polymer containing a fatty chain, methods and uses | KRT18, PLIN5, PLIN1 | SIGMAR1 2042/4885GRM2 4302/4885MAPT 1958/4885 |
| US-20040216245-A1 | Dyeing composition comprising a cationic tertiary para-phenylenediamine and a para-aminophenol, methods and uses | KRT18, CDC73, NUP205 | SIGMAR1 3023/4885GRM2 4488/4885MAPT 1322/4885 |
| US-20040211010-A1 | Dye composition comprising a cationic tertiary para-phenylenediamine and a polyol ester, processes therefor and uses thereof | KRT18, PPHLN1, PKLR | SIGMAR1 1639/4885GRM2 4823/4885MAPT 1287/4885 |
| US-20040250356-A1 | Dyeing composition comprising a cationic tertiary para-phenylenediamine and a particular pearlescent or opacifying agent, methods and uses | KRT18, CDC73, PPHLN1 | SIGMAR1 2644/4885GRM2 4725/4885MAPT 464/4885 |
| US-20100263138-A1 | COMPOSITION OXIDATION COLOURING OF KERATINIC FIBRES, CONTAINING A CATIONIC CELLULOSE ETHER, A METASILICATE AND OXIDATION DYES, METHOD FOR OXIDATION COLOURING AND USES THEREOF | KRT18, TUBB3, VIM | SIGMAR1 2837/4885GRM2 4792/4885MAPT 522/4885 |
| US-20040216243-A1 | Dye composition comprising a cationic tertiary para-phenylenediamine and a surfactant, processes therefor and uses thereof | KRT18, NOTUM, PHOSPHO1 | SIGMAR1 286/4885GRM2 4443/4885MAPT 2025/4885 |
| US-20040216244-A1 | Dyeing composition comprising a cationic tertiary para-phenylenediamine and an organic diacid, methods and uses | KRT18, CDC73, DDC | SIGMAR1 3049/4885GRM2 4712/4885MAPT 1376/4885 |
| US-20040226109-A1 | Dye composition comprising a cationic tertiary para-phenylenediamine and a polyol, process therefor and use thereof | FARSB, PARN, PKLR | SIGMAR1 156/4885GRM2 4645/4885MAPT 1812/4885 |
| US-20040205904-A1 | Dye composition comprising a cationic tertiary para-phenylenediamine and a vitamin derivative, processes therefor and uses thereof | KRT18, PPHLN1, PYCR1 | SIGMAR1 3323/4885GRM2 4861/4885MAPT 1738/4885 |
| US-20040231067-A1 | Dyeing composition comprising a cationic tertiary para-phenylenediamine and heterocyclic coupler, methods and uses | KRT18, CDC73, PYCR1 | SIGMAR1 2264/4885GRM2 4016/4885MAPT 1406/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.